Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

UK cost agency backs drugs for breast cancer

LONDON (Reuters) - British women with a family history of breast cancer could be offered two drugs to try to prevent the disease under draft guidelines published by the country's healthcare cost watchdog.

Cancer studies often downplay chemo side effects

NEW YORK (Reuters Health) - Doctors relying on studies published in top journals for guidance about how to treat women with breast cancer may not be getting the most accurate information, according to a new analysis.

Medicare spends $1 billion on mammograms: study

NEW YORK (Reuters Health) - Screening women for breast cancer costs the U.S. Medicare program $1 billion every year - about as much as it spends on treatment, according to a new study.

Study links milk-producing protein to aggressive breast cancer

HONG KONG (Reuters) - The discovery that a protein that triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.

Care and Outcome Differ for African-American Women

A report issued by the U.S. Centers for Disease Control and Prevention shows that African-American women are diagnosed with breast cancer less often than white women but continue to experience higher death rates. 

African-American Women Overtreated in Cancer Staging Process

An analysis of data collected in the Surveillance, Epidemiology and End Results (SEER)-Medicare database between 2002 and 2007 shows that though newer, less invasive breast cancer staging procedures have become standard, African-American women were 12 percent less likely to have the less invasive surgery than their white peers. 

Taking Tamoxifen for 10 Years Lowers Recurrence and Mortality

Tamoxifen treatment for estrogen receptor-positive breast cancer is even more beneficial when taken for 10 years instead of five. 

2012 Guidelines for Breast Cancer Follow-Up Released

The American Society of Clinical Oncology recently published the results of its most current guidelines for follow-up care of women who completed treatment for primary breast cancer. The 2012 findings, published online in the Journal of Clinical Oncology in November, determined that no change to the existing guidelines is necessary.

Acupuncture Shows Promise in Treating Fatigue

Women with moderate cancer-related fatigue may benefit from acupuncture treatment, a recent clinical trial found. The study supports past research that shows acupuncture may help manage fatigue caused by cancer and other factors. 

Possible New Treatment for Metastatic Breast Cancer

Results of an early analysis of a phase II clinical trial presented at the 2012 San Antonio Breast Cancer Symposium show that combining the aromatase inhibitor letrozole with the study medicine PD-0332991 increased median progression-free survival by 18.6 months compared to taking letrozole alone.